Chemkart India SME: Check IPO Date, Live Subscription and Key Details
Chemkart India Limited, established in 2020 (though some sources indicate 2015), is a leading B2B distributor and processor of high-quality Food & Health ingredients in India. The company bridges the gap between global ingredient manufacturers and businesses in the nutraceuticals, pharmaceuticals, food processing, health, and wellness industries. Its product categories span Amino Acids, Health Supplements, Herbal Extracts, Nucleotides, Proteins, Sports Nutrition, and Vitamins. While the majority of revenue (95.88% in FY25) is derived from trading operations, Chemkart also provides value-added services like processing, grinding, blending, packaging, labeling, and sealing of nutraceutical ingredients.
Min Investment
₹148800
Price Range
₹236.00-248.00
Issue Size
₹75.96 Cr
IPO Type
BSE SME
Key Metrics
Check Live GMP
Face Value
₹10
EPS
20.05
P/E Ratio
12.37
RoNW
45.52%
ROE
59%
Debt to Equity
0.32
Timeline
IPO Opens
7 Jul
IPO Closes
9 Jul
Allotment
10 Jul
Listing
14 Jul
IPO Objectives
- Financing the capital expenditure towards setting up of the Manufacturing Facility through investment in the Wholly-Owned Subsidiary (WOS) Company, Easy Raw Materials Private Limited.
- Repayment/prepayment of all or certain of the borrowings availed of by the Company.
- General Corporate Purpose.
Strengths
- Diversified product portfolio across seven categories (Amino Acids, Health Supplements, Herbal Extracts, Nucleotides, Proteins, Sports Nutrition, and Vitamins), catering to a broad range of nutraceutical needs.
- In-house processing and warehousing capabilities (28,259.16 sq. ft. facility in Bhiwandi, Mumbai) with grinding and blending capacities, allowing for value-added services like custom ingredient blends and efficient supply chain management.
- Strong B2B relationships and a widespread customer network, acting as a bridge between global ingredient manufacturers and Indian businesses in the health and wellness industry.
- Experienced Management team and skilled employees, including founder Ankit Mehta, who has driven the company's growth and established its reputation for reliability.
- Long-standing relationships with various Cybersecurity OEM Developers (this appears to be a copy-paste error from another company; correct strength is long-standing relationships with global ingredient manufacturers and suppliers).
Weaknesses
- Heavy dependence on imports (86.19% of sales in FY25) for raw materials and finished products, exposing the company to foreign exchange rate fluctuations, supply chain disruptions, and geopolitical risks.
- High revenue concentration: The company's sales are predominantly in India (99.3% in FY25), and a significant portion of its product sales come from amino acids (44.4%) and sports nutrition (33.23%), making it vulnerable to market shifts in these specific categories and geographies.
- Predominantly a trading-based business model (95.88% of revenue from trading in FY25), which typically has thinner margins compared to manufacturing or formulation services, potentially capping long-term margin expansion.
- High dependency on a limited number of suppliers for raw materials and products, with no long-term supply agreements, creating a significant operational risk if these partnerships are disrupted.
- Working capital intensive business, as evidenced by a stretched cash conversion cycle (109 days in FY25) and increased inventory days, which can strain liquidity.
Financial Performance
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets (₹ Cr.) | 86.12 | 53.51 | 37.48 |
| Revenue (₹ Cr.) | 205.46 | 132.83 | 131.69 |
| PAT (₹ Cr.) | 24.26 | 14.52 | 7.66 |
| Net Worth (₹ Cr.) | 53.29 | 29.01 | 14.5 |
Peer Comparison
| Company | P/B Ratio | P/E Ratio | RONW (%) | Net Worth (₹ Cr.) |
|---|---|---|---|---|
| Chemkart India Limited | 8.12 | 12.37 | 59 | 53.29 |
| Tac Infosec Limited | 21.37 | 88.06 | 24.27 | 14.11 |
| Quick Heal Technologies Ltd | 4.76 | 418.33 | 1.14 | 437 |
Subscription Details
Daily Bids Status
| Date | Day 1 | Day 2 | Day 3 |
|---|---|---|---|
| QIB | 0.80x | 3.41x | 13.69x |
| NII | 1.46x | 1.86x | 5.64x |
| RII | 0.10x | 0.26x | 1.61x |
| Total | 0.59x | 1.50x | 5.90x |
Overall Subscription Statistics
| Category | Shares Offered | Shares Bid | Bid Amount (₹ Cr) |
|---|---|---|---|
| QIB | 6,09,600 | 83,47,800 | 207.03 |
| NII | 4,63,200 | 26,11,200 | 64.76 |
| RII | 10,78,800 | 17,32,800 | 42.97 |
| Total | 21,51,600 | 1,26,91,800 | 314.76 |
Company Details
- Office No. 403/404, 4th Floor, K.L. Accolade, 6th Road, TPS III, Santacruz (East), Mumbai, Maharashtra-400055, India
- +91 9136383828
- investors@chemkart.com
- https://chemkart.com/
Registrar Details
- Bigshare Services Pvt Ltd
- +91-22-6263 8200
- ipo@bigshareonline.com
- https://ipo.bigshareonline.com/IPO_Status.html